The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center
Open accessAbstract
OBJECTIVE: To describe the clinical and microbiological features associated with fungal peritonitis in peritoneal dialysis (PD) patients at Hôpital Maisonneuve-Rosemont, from August 1996 to July 2006. METHODS: Cases were retrieved from the microbiology laboratory culture registry. Antifungal susceptibility was determined by the Clinical and Laboratory Standards Institute M27A3 method. RESULTS: Among 288 PD patients (total follow-up of 7258 patient-months), nine were found with fungal peritonitis. Candida spp were identified in all of them, with a majority of non-albicans Candida species. Resistance to fluconazole, itraconazole, or voriconazole was as frequent as potential resistance to amphotericin B. No isolate was resistant to caspofungin and one was resistant to micafungin. Prior bacterial peritonitis was frequent (67%). All patients had their PD catheter removed and all of them survived. CONCLUSIONS: In our institution, fungal peritonitis in PD patients is rare. All cases were caused by Candida species. Variable susceptibility patterns were observed, which may influence the initial empirical antifungal therapy and underscore the importance of individual speciation and susceptibility testing of invasive Candida isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The high morbidity and mortality of Candida peritonitis in developed countries has been associated with the age of patients, the use of antibiotics and corticosteroid treatment [48,49,50,51].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nomoto, Y., Kawaguchi, Y., Kubo, H., Hirano, H., Sakai, S., & Kurokawa, K. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90501-6 · Cited by 253 · cited 1×
“Previous peritonitis, either bacterial of fungal, may predispose to sclerosing peritonitis.(16,17) In conclusion, fungal peritonitis is a rare complication of PD that is associated with significant morbidity and mortality.”
BackgroundEncapsulating Peritoneal Sclerosis in the New Millennium: A National Cohort Study
Brown, M. C., Simpson, K., Kerssens, J. J., & Mactier, R. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01260209 · Cited by 197
Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes
Goldie, S. J., Kiernan-Troidle, L., Torres, C., Gorban-Brennan, N., Dunne, D., Kliger, A. S., & Finkelstein, F. O. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90135-3 · Cited by 189 · cited 2×
“Wang et al., 2000, 70 cases;8 Goldie et al., 1996, 55 cases;9 Nagappan et al., 1992, 38 cases;10 Prasad et al., 2004, 28 cases;11 Michel et al., 1994, 20 cases12), antifungal susceptibility testing of isolates has been reported in only two series.”
BackgroundResultWang, A. Y. M., Yu, A. W. Y., Li, P. K. T., Lam, P. K. W., Leung, C. B., Lai, K. N., & Lui, S. F. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.19833 · Cited by 186 · cited 1×
“Wang et al., 2000, 70 cases;8 Goldie et al., 1996, 55 cases;9 Nagappan et al., 1992, 38 cases;10 Prasad et al., 2004, 28 cases;11 Michel et al., 1994, 20 cases12), antifungal susceptibility testing of isolates has been reported in only two series.”
BackgroundPredictors and outcomes of fungal peritonitis in peritoneal dialysis patients
Miles, R., Hawley, C. M., McDonald, S. P., Brown, F. G., Rosman, J. B., Wiggins, K. J., Bannister, K. M., & Johnson, D. W. (2009) · Kidney International · doi:10.1038/ki.2009.202 · Cited by 162 · cited 5×
“Although larger series of FP in PD have already been published (Miles et al., 2009, 162 cases”
BackgroundResultInfluentialUpdate on Fungal Peritonitis and its Treatment
Matuszkiewicz‐Rowińska, J. (2009) · Peritoneal Dialysis International · doi:10.1177/089686080902902s31 · Cited by 161 · cited 3×
“It represents only 3% to 6% of all episodes of peritonitis, but is associated with much greater morbidity and mortality than bacterial peritonitis.(1) Initial empirical antifungal therapy has to take into account the frequency of different species of fungi based on the local epidemiology, and their susceptibilities to…”
BackgroundResultKartsonis, N. A., Killar, J., Mixson, L. A., Hoe, C., Sable, C. A., Bartizal, K. F., & Motyl, M. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3616-3623.2005 · Cited by 138 · cited 1×
“The clinical significance of such observations remains to be determined.(6,14) It however underscores the importance of individual speciation and susceptibility testing of invasive Candida isolates.”
BackgroundFungal Peritonitis in Peritoneal Dialysis Patients
Prasad, N., & Gupta, A. (2005) · Peritoneal Dialysis International · doi:10.1177/089686080502500302 · Cited by 113 · cited 5×
“All patients survived in our study, in contrast to a reported lethality of FP of between 5% and 50%.(2) The reason for this is probably multifactorial, including the relatively small number of cases in this study, the absence of fungus other than Candida in our series, and the fact that all patients had their catheter…”
BackgroundResultInfluentialFungal Peritonitis in Patients on Peritoneal Dialysis
Michel, C., Courdavault, L., Khayat, R., Viron, B. M., Roux, P., & Mignon, F. (1994) · American Journal of Nephrology · doi:10.1159/000168699 · Cited by 107
Prasad, K. N., Prasad, N., Gupta, A. K., Sharma, R. K., Verma, A. K., & Ayyagari, A. (2003) · Journal of Infection · doi:10.1016/s0163-4453(03)00119-1 · Cited by 103 · cited 1×
“Wang et al., 2000, 70 cases;8 Goldie et al., 1996, 55 cases;9 Nagappan et al., 1992, 38 cases;10 Prasad et al., 2004, 28 cases;11 Michel et al., 1994, 20 cases12), antifungal susceptibility testing of isolates has been reported in only two series.”
Background
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment
Li, P. K.-T., Szeto, C. C., Piraino, B., de Arteaga, J., Fan, S., Figueiredo, A. E., Fish, D. N., Goffin, E., Kim, Y.-L., Salzer, W., et al. (2016) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2016.00078 · Cited by 907
“Although fluconazole is commonly used, the prevalence of azole resistance is increasing (403).”
BackgroundPeritoneal dialysis-related peritonitis: challenges and solutions
Salzer, W. L. (2018) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s123618 · Cited by 158
“may become resistant.(65) In the event of fluconazole-resistant organisms, therapy with amphotericin B 0.”
Recent trends in molecular diagnostics of yeast infections: from PCR to NGS
Arastehfar, A. A., Boekhout, T., Butler, G., Cesare, G. B. D., Dolk, E., Gabaldón, T., Hafez, A. I., Hube, B., Hagen, F., Hovhannisyan, H., et al. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz015 · Cited by 152
Inflammation in Peritoneal Dialysis
Lai, K. N., & Leung, J. C. K. (2010) · Nephron Clinical Practice · doi:10.1159/000314544 · Cited by 79
“Fungal peritonitis accounts for about 4–6% of episodes of the total incidence of the peritonitis, and is with high mortality [14].”
Candida parapsilosis complex in the clinical setting
Govrins, M. A., & Lass‐Flörl, C. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00961-8 · Cited by 94
Characteristics and Outcomes of Fungal Peritonitis in a Modern North American Cohort
Nadeau‐Fredette, A., & Bargman, J. M. (2014) · Peritoneal Dialysis International · doi:10.3747/pdi.2013.00179 · Cited by 53
“Similar rates have been reported in previous publications, both for FP incidence per patient-year and proportion of global peritonitis (1,2,7,8).”
BackgroundResultSelf-citationFungal peritonitis in peritoneal dialysis: 5-year review from a North China center
Hu, S., Tong, R., Yang, B., Ming, P., & Yang, H. (2018) · Infection · doi:10.1007/s15010-018-1204-7 · Cited by 48
Giacobino, J., Montelli, A. C., Barretti, P., Bruder-Nascimento, A., Caramori, J. C. T., Barbosa, L., & Bagagli, E. (2016) · Medical Mycology · doi:10.1093/mmy/myw030 · Cited by 41
Leelahavanichkul, A., Somparn, P., Bootprapan, T., Tu, H., Tangtanatakul, P., Nuengjumnong, R., Worasilchai, N., Tiranathanagul, K., Eiam‐Ong, S., Levine, M., et al. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00238.2014 · Cited by 37
“The increasing prevalence of nosocomial fungal infection in cases of sepsis may be due to the growing use of broad-spectrum antibiotics coupled with the advancement of intensive care supports (8, 29, 37, 43, 59).”
Ito, Y., Ryuzaki, M., Sugiyama, H., Tomo, T., Yamashita, A. C., Ishikawa, Y., Ueda, A., Kanazawa, Y., Kanno, Y., Itami, N., et al. (2021) · Renal Replacement Therapy · doi:10.1186/s41100-021-00348-6 · Cited by 36
Peritoneal dialysis-related infections recommendations: 2016 update. What is new?
Liakopoulos, V., Nikitidou, O., Kalathas, T., Roumeliotis, S. K., Salmas, M., & Eleftheriadis, T. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1632-9 · Cited by 32
“Still, the Committee highlights that the use of fluconazole could lead to azole resistance [59].”
BackgroundFungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation
Auricchio, S., Giovenzana, M. E., Pozzi, M., Galassi, A., Santorelli, G., Dozio, B., & Scanziani, R. (2018) · Clinical Kidney Journal · doi:10.1093/ckj/sfy045 · Cited by 31
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment
(2018) · Peritoneal Dialysis International · doi:10.3747/pdi.2018.00030 · Cited by 31
Intra-abdominal fungal infections
Rebolledo, M., & Sarria, J. C. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000433309.21148.f7 · Cited by 20
Li, R., Zhang, D., He, J., Ou, J., La, Z., Hu, X., Wu, J., Liu, H., Yu, P., Xu, Y., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.774946 · Cited by 16
Sharifynia, S., Badali, H., Sorkherizi, M. S., Shidfar, M. R., Hadian, A., Shahrokhi, S., Ghandchi, G., & Rezaie, S. (2016) · PubMed · Cited by 12
Edwards, J. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00258-7 · Cited by 20
Xu, Z., Qu, W., qiao, P. S., Zhu, Y., Yan, W., Shen, S., Wang, T., & Wang, T. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108941 · Cited by 8
van der Sluijs, A. V. E., Eekelschot, K. Z., Frakking, F. N. J., Haas, P., Boer, W. H., & Abrahams, A. C. (2020) · Peritoneal Dialysis International · doi:10.1177/0896860820923238 · Cited by 8
Ounsinman, T., Chongtrakool, P., & Angkasekwinai, N. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05441-5 · Cited by 8
Peritonitis in children on peritoneal dialysis
Alzabli, S. M., Alsuhaibani, M., BinThunian, M. A., AlShahrani, D. A., Anazi, A. A., Varghese, S., Rose, V., & Rahim, K. A. (2020) · International Journal of Pediatrics and Adolescent Medicine · doi:10.1016/j.ijpam.2020.09.001 · Cited by 6
“Meanwhile, the rate of fungal infections was in line with the findings of international studies [14].”
ResultChronic peritoneal dialysis in children: a single-centre experience in Jordan
Frehat, M., Alsalaita, G., Al-bderat, J., Alhadidi, A., Mohammad, S., Shaaban, A., & Almardini, R. I. (2020) · Sudanese Journal of Paediatrics · doi:10.24911/sjp.106-1578945921 · Cited by 5
Autophagy in peritoneal fibrosis
Su, H.-Y., Yang, J., Zou, R., An, N., Chen, X., Yang, C., Yang, H., Yao, C., & Liu, J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1187207 · Cited by 6
“, 2013; Nadeau-Fredette and Bargman, 2015), it has higher morbidity and catheter-related mortality (Levallois et al., 2012; Li et al., 2016a; Giacobino et al., 2016; Xu et al., 2022).”
BackgroundPeritoneal Dialysis Related Candida Peritonitis:A 16-year Single-Centre Experience
Narain, U., & Gupta, A. (2016) · Archives of Clinical Microbiology · Cited by 4
Clinical Features and Risk Factors of Fungal Peritonitis in Children on Peritoneal Dialysis
Fang, X., Cui, J., Zhai, Y., Liu, J., Rao, J., Zhang, Z., Chen, J., Liu, J., Miao, Q., Shen, Q., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.683992 · Cited by 5
“Previous study from Canada including 288 adult patients on PD showed that all 9 cases suffering from FP survived the episode, while only one patient resumed PD 12 months later (22).”
BackgroundFungal peritonitis in children on peritoneal dialysis at a tertiary care Centre
Alsuhaibani, M., Aldosari, E., Rahim, K. A., Alzabli, S. M., & AlShahrani, D. A. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02014-1 · Cited by 3
Evren, K., Akçay, E., Yücel, M., Bal, Z., Erdinç, F. Ş., Dinç, B., & Kalkancı, A. (2021) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20219718 · Cited by 3
The Latest in Peritoneal Dialysis
Peralta, A. A. (2013) · InTech eBooks · doi:10.5772/45910 · Cited by 3
Infectious Complications of Peritoneal Dialysis in Children
Neu, A. M., Warady, B. A., & Schaefer, F. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-66861-7_16 · Cited by 3
Peritoneal dialysis–associated peritonitis caused by acremonium sclerotigenum: a case report
Wang, J., Cheng, Y., Yan, Q., Li, D., Wang, R., & Liu, G. (2025) · BMC Nephrology · doi:10.1186/s12882-024-03884-5 · Cited by 2
“Currently, the primary treatment for fungal peritonitis remains the removal of the peritoneal dialysis catheter [12].”
Fungal infections in pediatric patients: challenges and considerations in treatment
Castagnola, E., Mariani, M., Ricci, E., Russo, C., Saffioti, C., & Mesini, A. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2574707 · Cited by 2
“It can also cause rare but severe peritonitis in patients undergoing peritoneal dialysis [5,6].”
Laham, J. A., AlShaaili, K. S., Sayed, H. M. E. E., Al-Kharusi, A. W., Kharusi, K. A., & Alamri, K. S. (2026) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/sjmms.sjmms_534_25 · Cited by 2
“[8,9] Most fungal infections are due to Candida spp. [10] FP , if not detected early and treated appropriately, is associated with increased morbidity and mortality.”
InfluentialPeritoneal Infections in Peritoneal Dialysis (PD Peritonitis)
Regunath, H., Ludwig, K. P., & Khanna, R. (2023) · Springer eBooks · doi:10.1007/978-3-030-62087-5_49 · Cited by 3
Candida glabrata PD-Associated Peritonitis: A Case Report
Emami, S., & Lew, S. Q. (2018) · Peritoneal Dialysis International · doi:10.3747/pdi.2018.00044 · Cited by 2
“The newer agents such as caspofungin and micafungin have been shown to be effective in the treatment of fungal peritonitis, with low resistance rates (3,4).”
BackgroundInfluentialRusso, A., Coppola, N., Torti, C., & Trecarichi, E. M. (2026) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlag006 · Cited by 1
Kitterer, D., Latus, J., Alscher, M. D., & Kimmel, M. (2016) · InTech eBooks · doi:10.5772/64005 · Cited by 1
“Further, in catheter‐related infections with or without formation of biofilms, catheter removal should be considered and fungal infections always require catheter removal [68].”
BackgroundClinical Implications of Candida Biofilms
Bernardo, S. M., Ilieva, V. P., Walraven, C. J., & Lee, S. A. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0302-9 · Cited by 3
Management of fungal peritonitis : a Moroccan single peritoneal dialysis unit experience
Koné, M. H., Bouattar, T., Fares, I., Benbella, M., Ouzeddoun, N., Bayahia, R., & Benamar, L. (2019) · Bulletin de la Dialyse à Domicile · doi:10.25796/bdd.v2i2.19413 · Cited by 1
Inflammation in Peritoneal Dialysis
Joseph, C. K., Chan, L. Y. Y., Neng, K., & Tang, S. C. W. (2013) · InTech eBooks · doi:10.5772/55964 · Cited by 2
End-stage kidney disease: towards shared decision-making and patient-reported outcomes
van der Sluijs, A. V. E. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1590 · Cited by 1
Peritoneal Infections in Peritoneal Dialysis (PD Peritonitis)
Regunath, H., Ludwig, K. P., & Khanna, R. (2021) · Springer eBooks · doi:10.1007/978-3-319-90760-4_49-1 · Cited by 1
Assessment of microbiological profile in peritoneal dialysis in patients with chronic kidney disease
Sornaranjani, M., Ramani, C. P., & Karuppasamy, K. (2022) · Panacea Journal of Medical Sciences · doi:10.18231/j.pjms.2022.058
Peritoneal Infections in Peritoneal Dialysis (PD Peritonitis)
Regunath, H., Ludwig, K. P., & Khanna, R. (2022) · Springer eBooks · doi:10.1007/978-3-319-90760-4_49-2
Renal Replasman Tedavileri ‘Derlemeler’
Genek, D. G., Bardak, S., Merhametsiz, Ö., Yeter, H. H., Yaşar, E., Yayar, Ö., Atılgan, K. G., Eroğlu, E., Cebeci, E., Oruç, M., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1022
Yan, H., Zhang, H., Qian, Y., Su, X., Shen, Y., Huang, J., Ni, Z., Gu, L., & Fang, W. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101395
Nochaiwong, S., Ruengorn, C., Noppakun, K., Koyratkoson, K., Chuamanochan, M., Chieosilapatham, P., Mongkhon, P., Wachiraphansakul, N., Vongchaiudomchoke, T., Ngamvichchukorn, T., et al. (2026) · Medical Sciences · doi:10.3390/medsci14050592
“…WHO region, the included studies were conducted in the African Region (2 studies, n = 292) [62,93], the Region of the Americas (21 studies, n = 30,425) [35, 41,43,44,46,47,57,65,71,75,85,95,99,105,117,129,139,144,150,163], the South-East Asia Region (16 studies, n = 13,837) [32–34, 39, 45, 63 3.3.”
Influential
Metadata
- Authors
- Levallois, J., Nadeau-Fredette, A.-C., Labbé, A.-C., Laverdière, M., Ouimet, D., & Vallée, M.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Corresponding author
- Vallée, Michel
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 16
- Issue
- 1
- Pages
- e41-e43
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2002605200
- Cited by
- 47
- References
- 16
- Citations by year
- 2026: 4 · 2025: 2 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 1 · 2013: 3
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 599 d)
- Locations
- International Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- fungal peritonitis, peritoneal dialysis, Candida, non-albicans Candida, antifungal susceptibility, fluconazole resistance, itraconazole resistance, voriconazole resistance, amphotericin B resistance, caspofungin, micafungin, peritoneal catheter removal, invasive candidiasis
- MeSH terms
- Caspofungin, Micafungin, Adult, Aged, Amphotericin B, Antifungal Agents, Candida, Female, Follow-Up Studies, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Mycoses, North America, Peritoneal Dialysis, Peritonitis, Pyrimidines, Triazoles, Fluconazole, Itraconazole, Drug Resistance, Fungal, Echinocandins, Lipopeptides, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.